Stifel raises Nlight stock price target to $75 on defense growth

Stifel raised Nlight’s price target to $75 from $68 and reiterated a Buy rating, reinforcing a constructive view after the stock’s 878% rally over the past year. The company reported 2025 revenue above $260 million, with Aerospace & Defense now accounting for more than 60% of sales and transitioning toward weaponized programs of record. The article also notes multiple analyst target increases and six upward earnings revisions, with Nlight expected to turn profitable this year.

Analysis

The market is beginning to re-rate LASR less like a cyclical photonics supplier and more like a defense platform with program-of-record optionality. That changes the multiple: once revenue is tied to procurement pathways and integration budgets, upside comes from manufacturing scale and backlog durability rather than mere technical validation. The second-order effect is that contract wins should increasingly crowd out commercial/industrial demand in the product mix, which can make reported growth look deceptively smoother even if underlying defense program timing remains lumpy.

The key near-term swing factor is not technology risk anymore; it is execution risk around production throughput, yield, and qualification cadence. If management can scale output without margin erosion, the stock can continue to de-risk into a higher-quality defense compounder multiple over the next 2-4 quarters. If not, the current valuation becomes vulnerable because the market is already extrapolating a rapid transition from prototype economics to volume economics.

The contrarian angle is that consensus may be underestimating procurement concentration risk. A few large defense programs can drive most of the upside, but they also create binary dependence on schedule, budget cycles, and platform adoption. In a risk-off tape, names with elevated expectations and defense policy sensitivity often mean-revert sharply on even modest delays, so the setup is attractive only if one is willing to tolerate program-level volatility rather than just headline momentum.

From a competitive standpoint, the likely losers are traditional defense primes and smaller photonics vendors that lack direct-contracting access or differentiated beam-combining architecture. If LASR continues to win as a prime rather than a subcontractor, it may pull margin pool away from integrators and force competitors to accept lower-value component roles. The broader supply chain implication is a likely increase in demand for specialty materials, high-end optics, and manufacturing tooling over the next 12-18 months.

Key Decisions for Investors

• Long LASR on pullbacks over the next 1-2 weeks; use a staged entry below near-term highs because momentum is extended, but the medium-term setup remains constructive if defense revenue keeps scaling. Target a 15-25% upside over 3-6 months with a hard stop on any sign of program delay or margin compression.
• Buy LASR call spreads 3-6 months out instead of outright shares if implied volatility is elevated; this captures continued rerating while limiting drawdown if the market fades the valuation premium.
• Pair trade: long LASR / short a diversified defense prime basket over 1-2 quarters if you want to express preference for direct-program exposure over legacy procurement exposure. The thesis is that LASR should outperform on incremental contract wins, but size modestly given binary execution risk.
• Avoid chasing after large gap-ups; wait for a post-earnings or contract-announcement consolidation to add exposure. The setup is strongest when the stock digests gains without losing the 20-day trend, which improves entry quality and reduces downside from sentiment reversal.
• For risk control, reduce exposure if the story shifts back toward technology validation rather than manufacturing scale. That would indicate the market is no longer paying for the transition to production economics, which would compress the multiple quickly.